COMPANY



Cécile Réal

Strategic Advisor

A biomedical engineer with a MBA, Cécile has 15 years of experience in medical industry and management of medical start-up companies.
President and founder of Bioprofile (1999-2007), specialised in innovative orthopaedic implants, she rapidly developed the company and gained strong experience in product development, business development and fund raising.


She developed an international distribution network and integrated Bioprofile within Nexa Orthopedics (USA)in 2005 before being acquired by Tornier in 2007.
She then served as COO at Ariana Pharma (2008-2011), a bioinformatics company specialized in biomarkers discovery.

 

In 2011, Cecile co-founded and became CEO of Endodiag, a diagnostics company specialised in endometriosis. Cecile is President of Medicalps (Grenoble Health Industry Cluster) and was laureat for Europe of the 2012 Cartier Women's Initiative Award.



Commitment

Fluoptics is working hard to develop innovative solutions to improve patient care and outcomes. We help to simplify the work of surgeons and by improving the efficiency of their procedures we also contribute to a reduction in operating costs.


Clinical and technology partnership


Fluoptics technology is based on a portfolio of patents from our research partners at the CEA-Léti, Université Joseph-Fourier, Inserm and the CNRS. Fluoptics products were developed and validated working closly with European clinical teams in order to design the best solution to the real needs of patients and the healthcare industry.